Scientists test tailored drug dosing to fight tough cancers
NCT ID NCT01552356
Summary
This early-stage study is testing a method to personalize the dose of a cancer drug called pazopanib for patients with advanced solid tumors. Researchers will check drug levels in patients' blood and adjust the dose to try to improve safety and effectiveness. The main goal is to find the best dose that achieves the target drug level while causing the fewest side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.